Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LOC401021 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
C11orf84 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LOC654342 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC9A9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDE4A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
H2BFM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GRIK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VSTM4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FUZ - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SHOX2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ITPKB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KCNT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ICOS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SLC25A4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FGFR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
USP12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IGHV4-31 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAPKAPK5-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on